# OnCo record invitae-common-hereditary-cancers-panel (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/invitae-common-hereditary-cancers-panel/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "invitae-common-hereditary-cancers-panel" ;
  schema:name "Invitae Common Hereditary Cancers Panel"@en ;
  schema:description "A blood test of 47 genes, authorised by the US regulator and ordered by a clinician, that finds inherited changes which raise cancer risk or explain a cancer already diagnosed."@en ;
  schema:url <https://onco.cc/drugs/invitae-common-hereditary-cancers-panel/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/denovo.cfm?id=DEN210011>, <https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN210011.pdf>, <https://www.ncbi.nlm.nih.gov/gtr/tests/528518/> ;
  onco:status "approved" ;
  onco:tag "test", "hereditary" ;
  onco:modality "Germline hereditary cancer sequencing panel test (FDA De Novo)" ;
  schema:alternateName "Invitae Common Hereditary Cancers Panel" ;
  onco:approval "US 2023: Hereditary cancer predisposition assessment and identification of hereditary variants potentially associated with a diagnosed cancer (De Novo DEN210011, prescription use)" ;
  onco:technologies <https://onco.cc/technologies/germline-testing/> ;
  onco:targets <https://onco.cc/targets/brca/>, <https://onco.cc/targets/palb2/>, <https://onco.cc/targets/mlh1/>, <https://onco.cc/targets/msh2/>, <https://onco.cc/targets/msh6/>, <https://onco.cc/targets/pms2/>, <https://onco.cc/targets/cdh1/>, <https://onco.cc/targets/stk11/>, <https://onco.cc/targets/mutyh/>, <https://onco.cc/targets/tp53/>, <https://onco.cc/targets/apc/>, <https://onco.cc/targets/nf1/> ;
  onco:companies <https://onco.cc/companies/invitae/> ;
  onco:terms <https://onco.cc/terms/hereditary-cancer-syndromes/>, <https://onco.cc/terms/lynch-syndrome/>, <https://onco.cc/terms/li-fraumeni/>, <https://onco.cc/terms/hereditary-diffuse-gastric-cancer/>, <https://onco.cc/terms/peutz-jeghers-syndrome/>, <https://onco.cc/terms/mutyh-associated-polyposis/>, <https://onco.cc/terms/juvenile-polyposis-syndrome/>, <https://onco.cc/terms/gapps/>, <https://onco.cc/terms/vus/> .